Home › Cancro del polmone non a piccole cellule › Florida › Deltona
Studi clinici su Cancro del polmone non a piccole cellule a Deltona, FL
15 studi su Cancro del polmone non a piccole cellule cercano partecipanti presso sedi a Deltona e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
In reclutamentoFase 1/2
- Mid Florida Hematology And Oncology Center /ID# 273777, Orange City · a 4 mi di distanza
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
In reclutamentoFase 3
- Mid Florida Hematology and Oncology Center ( Site 0018), Orange City · a 4 mi di distanza
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
In reclutamentoFase 3
- Alpha Clinical Research Centers LLC, Orange City · a 4 mi di distanza
- Florida Cancer Specialists, Orange City · a 4 mi di distanza
- Mid Florida Hematology and Oncology Center, Orange City · a 4 mi di distanza
- e altri 1
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
In reclutamentoFase 3
- Mid Florida Hematology and Oncology Center, Orange City · a 4 mi di distanza
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
In reclutamentoFase 1/2
- Mid Florida Hematology and Oncology Center, Orange City · a 4 mi di distanza
Pan-tumor MRD Study
In reclutamentoStudio osservazionale
- Mid Florida Cancer Centers, Orange City · a 4 mi di distanza
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
In reclutamentoFase 3
- Research Site, Orange City · a 4 mi di distanza
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
In reclutamentoFase 2/3
- Mid Florida Cancer Centers, Orange City · a 4 mi di distanza
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
In reclutamentoFase 3
- Mid Florida Hematology and Oncology Center, Orange City · a 4 mi di distanza
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
In reclutamentoFase 3
- Mid Florida Hematology and Oncology Center, Orange City · a 4 mi di distanza
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
In reclutamentoFase 2/3
- Local Institution - 007-926-B, Daytona Beach · a 26 mi di distanza
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
In reclutamentoFase 3
- Mid-Florida Hematology & Oncology Centers, P.A., Orange City · a 4 mi di distanza
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
In reclutamentoFase 3
- Research Site, Orange City · a 4 mi di distanza
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
In reclutamentoFase 1/2
- Mid Florida Hematology and Oncology Center, Orange City · a 4 mi di distanza
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
In reclutamentoFase 2
- Mid Florida Hematology and Oncology Center, Orange City · a 4 mi di distanza
Studi su Cancro del polmone non a piccole cellule in altre città
- Houston, TX145 studi
- New York City, NY120 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH56 studi
- Washington, DC55 studi
Altri studi a Deltona
- Obesità11 studi
- Diabete di tipo 210 studi
- Morbo di Alzheimer10 studi
- Sovrappeso9 studi
- Cancro al seno8 studi
- Cancro ai polmoni8 studi
- Cancro (tutti i tipi)7 studi
- Pressione alta5 studi
- Osteoartrite del ginocchio5 studi
- Cancro metastatico5 studi
- Melanoma5 studi
- BPCO4 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.